相关实验视频
Updated: Jul 23, 2025

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.6K
MDM2/p53轴在抗瘤免疫反应中的作用
Tilman Brummer1,2,3,4, Robert Zeiser2,3,4,5
1Faculty of Medicine, Institute of Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany.
Blood
|July 19, 2023
概括
抑制小鼠双分钟2同源 (MDM2) 可以恢复瘤抑制剂p53的功能,并增强抗瘤免疫力. 这种方法对治疗急性髓性白血病和固体瘤有前途,特别是与其他免疫疗法结合使用时.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 鼠标双分钟2同源 (MDM2) 负调节瘤抑制剂p53.
- 高MDM2表达在急性髓性白血病 (AML) 和固体瘤中很常见.
- 在AML中TP53突变表明预后不佳和复发风险增加.
研究的目的:
- 审查如何操纵MDM2和p53可以增强癌细胞免疫性.
- 讨论MDM2/p53调节癌症中与免疫相关的因素.
- 探索MDM2抑制作为癌症免疫治疗的策略.
主要方法:
- 关于MDM2和p53在癌症免疫中的作用的文献综述.
- 对MHC,dsRNA,干扰素,IL-15和TRAIL-Rs.的MDM2/p53调节的分析.
- 检查MDM2抑制对T细胞的影响和临床前/临床数据.
主要成果:
- 抑制MDM2可以恢复p53功能并增强抗瘤免疫力.
- MDM2/p53影响关键的免疫路径,包括MHC表达和细胞因子的产生.
- 抑制MDM2对T细胞的直接影响有助于免疫治疗.
结论:
- 抑制MDM2是恢复p53和增强抗瘤免疫力的有希望的策略.
- 向MDM2为血液性恶性瘤及其他疾病的联合免疫治疗提供了一种新的方法.
- 通过MDM2抑制恢复p53和直接影响T细胞,代表了一个新兴的免疫疗法概念.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K

